• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Steatotic Liver Disease in the US: The Impact of the New Nomenclature on Classification of Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease and Alcohol-Associated Liver Disease.

作者信息

Sedki Mai, Kim W Ray, Kwong Allison, Charu Vivek, Sripongpun Pimsiri, Mannalithara Ajitha

机构信息

Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Redwood City, California.

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Phoenix, Arizona.

出版信息

Gastro Hep Adv. 2025 Jan 28;4(5):100629. doi: 10.1016/j.gastha.2025.100629. eCollection 2025.

DOI:10.1016/j.gastha.2025.100629
PMID:40672117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12264219/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf19/12264219/011b09a866c4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf19/12264219/011b09a866c4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf19/12264219/011b09a866c4/gr1.jpg

相似文献

1
Steatotic Liver Disease in the US: The Impact of the New Nomenclature on Classification of Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease and Alcohol-Associated Liver Disease.美国的脂肪性肝病：新命名法对代谢功能障碍相关脂肪性肝病和酒精性肝病患者分类的影响。
Gastro Hep Adv. 2025 Jan 28;4(5):100629. doi: 10.1016/j.gastha.2025.100629. eCollection 2025.
2
Metabolic Dysfunction-Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population-Based Study.代谢功能障碍相关脂肪性肝病、饮酒与心房颤动风险：一项基于全国人口的研究
J Am Heart Assoc. 2025 Jul 15;14(14):e042003. doi: 10.1161/JAHA.125.042003. Epub 2025 Jul 14.
3
Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the community.社区中具有代谢和酒精风险个体的脂肪性肝病患病率、严重程度及决定因素
J Hepatol. 2025 Jul 4. doi: 10.1016/j.jhep.2025.06.020.
4
Impact of alcohol consumption and muscle mass on bone mineral density in metabolic dysfunction and alcohol-associated liver disease (MetALD) and metabolic dysfunction-associated steatotic liver disease (MASLD).饮酒量和肌肉量对代谢功能障碍与酒精相关肝病（MetALD）及代谢功能障碍相关脂肪性肝病（MASLD）患者骨密度的影响。
Clin Nutr ESPEN. 2025 Jul 7;69:145-153. doi: 10.1016/j.clnesp.2025.07.002.
5
Phosphatidylethanol and ethyl glucuronide to categorize alcohol consumption in alcohol-related cirrhosis.磷脂酰乙醇和葡萄糖醛酸乙酯用于对酒精性肝硬化中的酒精摄入进行分类。
JHEP Rep. 2025 Apr 24;7(8):101433. doi: 10.1016/j.jhepr.2025.101433. eCollection 2025 Aug.
6
Steatotic Liver Disease as a Risk Enhancer in the Presence of Metabolic Syndrome.脂肪性肝病作为代谢综合征存在时的风险增强因素。
Eur J Prev Cardiol. 2025 Jun 12. doi: 10.1093/eurjpc/zwaf330.
7
Cause-specific mortality in patients with steatotic liver disease in the United States.美国脂肪性肝病患者的病因特异性死亡率。
J Hepatol. 2025 May 24. doi: 10.1016/j.jhep.2025.05.013.
8
Adoption of the New Nomenclature of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) by the Indian National Association for Study of the Liver (INASL): Implications for the INASL Guidance Paper on NAFLD.印度国家肝脏研究协会（INASL）采用代谢功能障碍相关脂肪性肝病（MASLD）新命名法：对INASL非酒精性脂肪性肝病指南文件的影响
J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102590. doi: 10.1016/j.jceh.2025.102590. Epub 2025 May 16.
9
Association of metabolic dysfunction-associated steatotic liver disease and steatosis-associated fibrosis estimator with subclinical coronary atherosclerosis: observation cohort study.代谢功能障碍相关脂肪性肝病和脂肪变性相关纤维化评估指标与亚临床冠状动脉粥样硬化的关联：观察性队列研究
Sci Rep. 2025 Jul 10;15(1):24953. doi: 10.1038/s41598-025-10380-9.
10
Extrahepatic Events in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and the Impact of Genetics and Alcohol Intake.代谢功能障碍相关脂肪性肝病患者的肝外事件以及遗传因素和酒精摄入的影响
Hepatol Res. 2025 Jul 1. doi: 10.1111/hepr.14233.

本文引用的文献

1
National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature.采用共识命名法的脂肪肝疾病及其分类的全国流行率估计。
Hepatology. 2024 Mar 1;79(3):666-673. doi: 10.1097/HEP.0000000000000604. Epub 2023 Sep 20.
2
Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease.饮酒与代谢综合征：对肝脏疾病的临床和流行病学影响。
J Hepatol. 2023 Jan;78(1):191-206. doi: 10.1016/j.jhep.2022.08.030. Epub 2022 Sep 5.
3
Are there outcome differences between NAFLD and metabolic-associated fatty liver disease?
非酒精性脂肪性肝病（NAFLD）和代谢相关脂肪性肝病之间在结局上存在差异吗？
Hepatology. 2022 Nov;76(5):1423-1437. doi: 10.1002/hep.32499. Epub 2022 May 2.